Stemline Therapeutics Inc
Pharmaceutical company · New York, United States
Stemline Therapeutics Inc is a pharmaceutical company headquartered in New York, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $349,570 in total, most recently in 2006. It has reported private securities offerings to the US SEC, most recently $740,000 sold in a notice filed in 2012.
Stemline Therapeutics at a glance
What does Stemline Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $349,570 in total (2006).
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $740,000 sold (2012).
Frequently asked questions about Stemline Therapeutics
Where is Stemline Therapeutics headquartered?
Stemline Therapeutics Inc is headquartered in New York, United States.
What does Stemline Therapeutics do?
Stemline Therapeutics Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.